Endocrine Abstracts

Controversy remains as to the risk of cardiovascular disease (CHD) associated with subclinical hypothyroidism (SCH). Substantial evidence indicates altered cholesterol and lipoprotein metabolism in SCH when serum TSH is above 10 mUI/l. It is apparent that an enhanced CV risk could apply to these patients, amplified by the co-presence of other risk factors such as endothelial dysfunction and elevated C-reactive protein.We assessed the association between ...